Company intelligence / Profile preview

Onexio Biosystems

Austin, Texas, United Statesonexiobio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Onexio Biosystems has developed and commercialized the microDUO high-throughput screening platform, which enables co-culture and multi-culture assays in standard ANSI/SLAS-format plates. This allows researchers to model intercellular interactions more accurately during drug discovery and chemical safety testing. The system is compatible with standard HTS workflows, requires minimal specialized training, and offers cost-effective alternatives to traditional co-culture methods[2][3][4][5].

Modalities: DevicePlatform technology for cell-based assays
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Onexio Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onexio Biosystems.

Explore the full profile